Valuation Basilea Pharmaceutica AG

Stocks

Market Closed - Swiss Exchange 16:31:10 26/10/2026 GMT			5-day change	1st Jan Change
68.90 ^CHF	+0.58%		+1.92%	+25.96%

10-20	Basilea Pharmaceutica Ltd Announces Presentation Of New Data For Fosmanogepix, Isavuconazole And Ceftobiprole At IDWeek 2026	CI
09-14	Japanese Stocks Fall on AI Development Slowdown Calls; Oil Gains	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	484.7	545.8	422.9	501.2	672.1	855.8	-	-
Change	-	12.62%	-22.52%	18.52%	34.1%	27.32%	-	-
Enterprise Value (EV) ¹	552.8	630	473.9	472.6	585.2	698.6	638.4	633
Change	-	13.97%	-24.78%	-0.28%	23.84%	19.37%	-8.62%	-0.84%
P/E	-70.6x	44.9x	41x	7.09x	17.4x	14x	16.6x	85.1x
PBR	-	-	-42.3x	6.17x	5.26x	4.52x	3.34x	3.49x
PEG	-	-0x	-2.6x	0x	-0.4x	0.2x	-1.1x	-1.1x
Capitalization / Revenue	3.27x	3.69x	2.68x	2.4x	2.89x	3.17x	2.99x	4.07x
EV / Revenue	3.73x	4.26x	3.01x	2.27x	2.52x	2.59x	2.23x	3.01x
EV / EBITDA	287x	32.1x	22.8x	7.51x	11x	9.04x	11.1x	45.4x
EV / EBIT	461x	34.1x	24.7x	7.72x	11.4x	9.41x	11x	55x
EV / FCF	-16.8x	168x	35.9x	6.51x	9.88x	8.22x	11.1x	48x
FCF Yield	-5.94%	0.6%	2.79%	15.4%	10.1%	12.2%	8.99%	2.09%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.58	1.02	0.86	5.83	3.14	4.921	4.158	0.8095
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	148.1	147.8	157.6	208.5	232.4	269.7	285.8	210.3
EBITDA ¹	1.926	19.64	20.78	62.91	53.36	77.28	57.56	13.93
EBIT ¹	1.2	18.5	19.2	61.2	51.5	74.25	58.1	11.51
Net income ¹	-6.8	12.15	10.5	77.6	40.2	68.15	57.8	6.412
Net Debt ¹	68.1	84.17	50.98	-28.65	-86.9	-157.2	-217.4	-222.7
Reference price ²	40.92	45.80	35.30	41.35	54.70	68.90	68.90	68.90
Nbr of stocks (in thousands)	11,844	11,918	11,980	12,121	12,288	12,420	-	-
Announcement Date	15/02/22	14/02/23	13/02/24	18/02/25	17/02/26	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BASILEA PHARMACEUTICA AG	13.92x	2.57x	8.98x	-.--%	1.03B
WUXI APPTEC CO., LTD.	18.83x	6.63x	13.18x	1.58%	64.69B
ARGENX SE	30.16x	8x	26.2x	0.05%	54.78B
LONZA GROUP AG	36.79x	6.53x	19.51x	0.88%	53.49B
IQVIA HOLDINGS INC.	35.59x	3.45x	14.87x	-.--%	45.98B
BEONE MEDICINES AG	49.71x	5.74x	31.52x	-.--%	42.94B
REVOLUTION MEDICINES, INC.	-19.41x	187.75x	-20.66x	-.--%	40.08B
CELLTRION, INC.	28.93x	8.21x	21.27x	0.37%	33.52B
WUXI BIOLOGICS (CAYMAN) INC.	27.67x	5.83x	15.12x	-.--%	23.97B
GENMAB A/S	32.59x	5.97x	20.28x	-.--%	23.67B
Average	25.48x	24.07x	15.03x	0.29%	38.41B
Weighted average by Cap.	26.68x	25.26x	15.89x	0.43%